Adenosine, acting on A2A adenosine receptors, regulates addictive processes induced by drugs of abuse. The present study investigates the role of A2A adenosine receptors in neurochemical and behavioural responses to an acute cocaine challenge.
Introduction
Adenosine, an endogenous neuromodulator, has been implicated in a number of pathophysiological processes, including drug addiction (Hack and Christie 2003) . Adenosine exerts its biological effects through the activation of four G-protein coupled receptor types: A1, A2A, A2B and A3 (Fredholm et al. 2001) . A2A receptors (A2AR) are highly expressed in the CNS; their distribution is restricted to areas involved in the control of motivational responses, such as the dorsal (caudate-putamen; CPu) and the ventral striatum, including the nucleus accumbens (NAc) and olfactory tubercules (OT) (Johansson et al. 1997; Moreau and Huber 1999) .
The role of mesolimbic dopamine (DA) in reinforcing behaviours and reward has been extensively reported (Di Chiara and Imperato 1988; Koob 1992; Everitt et al. 1999) and adenosine regulates dopaminergic transmission through the activation of A1 and A2A receptors. A2AR are expressed on somatodendritic sites of striatopallidal neurons and are colocalised with D2-like receptors and type I metabotropic glutamate receptors (Schiffmann et al. 1991; Fink et al. 1992; Ferre et al. 1997; Ferre et al. 2002) . There is evidence to support a direct physical interaction between A2A and D2/3 receptors, and the existence of A2A-D2 heteromeric receptor complexes with reciprocal antagonistic interactions being reported.
InadditionIn addition, A2A-mGluR5 heterometric complexes with synergistic agonistic interactions have also been described (Ferre et al. 1999; Ferre et al. 2002; Fuxe et al. 2005; Torvinen et al. 2005) .
Mice globally lacking the A2AR have demonstrated altered neurobiological and behavioural responses to opioids, cannabinoids and psychostimulants. Naloxone-precipitated withdrawal after chronic morphine administration, leads to an increase of withdrawal signs in A2AR knockout (A2AR KO) mice in comparison to wildtype (WT) littermates (Berrendero et Wells et al. 4 al. 2003; Bailey et al. 2004 ). Furthermore, Mu-opioid receptor (MOR) stimulated [ 35 S]GTPS binding reveals a significant increase in MOR functional activation in the NAc of withdrawn A2AR KO mice (Bailey et al. 2004 ). However, the rewarding and aversive responses induced by an acute morphine challenge are absent in these mice (Castane et al, 2008) , suggesting that the A2AR receptor has a differential role in somatic and motivational effects of morphine addiction. The rewarding properties of nicotine as measured by condition-place preference (CPP) and dopaminergic neurotransmission are blunted in A2AR KO mice ).Moreover, 9-tetrahydrocannabinol induced reward and aversion (CPP) are abolished whereas rimonabant-precipitated 9-tetrahydrocannabinol withdrawal is reduced in mice lacking the A2AR (Soria et al. 2004 ).
In addition, the response to psychostimulants is altered in mice lacking A2A
Rreceptors. Contrary to pharmacological data (Filip et al. 2006) , studies using A2AR KO mice generated on 129-Steel or hybrid C57BL/129-Steel genetic backgrounds found the lack of A2AR receptors attenuates ambulatory activity in mice induced by amphetamine and cocaine.
Moreover, amphetamine-induced behavioural sensitisation and changes in striatal dynorphin mRNA levels are abolished in A2AR KO mice (Chen et al. 2000; Chen et al. 2003) .
Interestingly, mice with a selective genetic deletion of the A2AR in the striatum are found to be more representative of pharmacological challenges and express the opposite phenotype to mice with fore-brain specific deletion when challenged with cocaine or phencyclidine (Shen et al. 2008) . Investigations using A2AR KO mice generated on the outbred CD-1 background (Ledent et al. 1997 ) show a significant difference in cocaine maintained operant selfadministration between WT and A2AR KO mice, with KO mice displaying a significantly lower cocaine intake and a significantly lower breaking point as measured by a progressive ratio schedule. This suggests that the reinforcing efficacy of cocaine is decreased in A2AR KO Wells et al. 5 mice. These studies indicate an important role for the adenosine A2AR receptor in the actions of cocaine .
To further elucidate the role of the A2AR receptor in the adenosinergic modulation of the rewarding properties of cocaine, the effects of acute systemic cocaine administration on extracellular DA in the NAc was evaluated in wildtype and mice globally lacking the A2AR receptor. In addition, locomotor behaviour and small local movements (stereotypy) during dialysis procedures were evaluated. Wells et al. 6
Material and Methods
Drug and molecular target nomenclature conforms to Br. J. Pharmacol. Guide to Receptors and Channels (Alexander et al., 2008) . Cocaine was purchased from Sigma Chemical Co (Dorset, U.K.) and was dissolved in sterile 0.9 % sterile physiological saline.
The methods were carried out as detailed in Castane et al. 2008 and are described in brief below. Male Mmice lacking A2AR were generated on a CD1 background as previously reported (Ledent et al., 1997) and maintained at the University of Surrey. Heterozygoteheterozygote matings of A2AR KO mice produced wild-type (WT) and KO littermates for subsequent experiments. All microdialysis procedures were carried out in the same building in which the mice were housed and in accordance with the guidelines of the UK Animal Act 1986 (Scientific Procedures). Mice were handled for five days before starting the experiments.
Microdialysis studies
One day prior to microdialysis, mice (12-15 week old) were anaesthetized and a guide cannula (CMA 7, CMA microdialysis, Sweden) stereotaxically implanted targeting the left NAc core-shell border (AP: +1.5 mm, L: -0.9 mm, DV: -4.0 mm). Microdialysis was carried out in freely-moving mice. Animals were equilibrated in a locomotor cage 1 hr prior to the start of microdialysis. A microdialysis probe (CMA/7/7, 1mm membrane), perfused with artificial cerebrospinal fluid (aCSF) (NaCl, 145 mM; KCL, 2.8 mM; CaCl2, 1.3 mM, MgCl2, 1.2 mM) at 1l.min -1 , was inserted into the guide cannula. Dialysate was collected for 2 hr and discarded to ensure a stable basal DA level. Subsequently, dialysate fractions were collected at intervals of 20 min for 100 min. Animals were then injected with saline (5 ml kg -7 Following this, high potassium aCSF ([50mM]K + aCSF)) was perfused and a further four sample fractions were collected. All sample fractions were collected directly into 35 l of acidic HPLC mobile phase and frozen immediately in dry ice.
After the completion of the microdialysis procedure, mice were killed by cervical dislocation.Coronal cryostat sections (20 m) of brain were cut and probe placement was checked visually using hematoxilin and eosin histological staining. Only data obtained from animals with correct probe tracts were used for analysis.
Dopamine Analysis
DA concentration in the dialysate was determined by HPLC with electrochemical detection (Coulochem II, ESA Analytical Ltd, UK) which comprised a dual porous graphite electrode system (screening electrode at -70 mV and working electrode at +190 mV; guard cell at +400 mV). A Spherisorb ODS2 analytical column (100 mm x 4.6 mm x 5mm, Waters Ltd, UK) with a guard column (Phenomenex, UK) were used. The mobile phase consisted of 0.05 M NaH2PO4, 0.8 mM OSA, 0.1 mM EDTA and 10% methanol, pH 3.3. Dialysate DA concentrations were quantified by external standard curve calibration, using peak area for quantification; data were not corrected for probe recovery.
Monitoring of ambulation
Locomotion, small local movements and resting behaviours were measured (TruScan, Bilaney Consultants, U.K) during the microdialysis procedure. Two sensor rings; each with 32 x 32 photobeams, were set 2cm (horizontal activity) and 6cm (vertical activity) from the cage floor. Each animal's accumulated basal activity was measured for 100min.. The acquisition software was paused to allow the mouse to be administered either challenge (saline or 8 cocaine) within the locomotor chamber and resumed for another 220 min to record challengeinduced movements and movement during post-challenge high potassium evoked DA release.
Statistical analysis
Acute effects of cocaine on extracellular levels of DA were analysed using a multifactorial ANOVA with time (T), genotype (G, WT or KO) and challenge (C, saline or cocaine) as factors of variation, with Duncans Multiple Range post hoc analysis. Data from the high potassium effects on extracellular levels of DA are presented as aArea under the curve (AUC) values, represented as the DA increase from the basal levels. AUC was calculated by using a standard trapezoid method (Gibaldi and Perrier 1975) and were analyzed by using Student's ttests with P ≤< 0.05 as the level of significance
Comparison of locomotion (as absolute values, distance in mm) was made between treated animals, using three-way repeated measures ANOVA followed by Duncans post-hoc analysis, for the factors of time (T), genotype (G) and challenge (C) The significance level for all tests was P ≤ 0.05. The data are expressed as mean± SEM. 
Results

Decreased cocaine-evoked extracellular dopamine in the NAc of A2AR KO mice
The extracellular levels of DA in the NAc were assessed by microdialysis in freely-moving WT and adenosine A2AR KO mice (n = 5 for saline-treated WT mice, n = 6 for saline-treated KO mice, n = 5 for cocaine-treated WT mice, n = 7 for cocaine-treated KO mice). Basal extracellular DA levels measured over five dialysate collections (100 min) were not significantly different in WT (1.37 ± 0.15 nM, n = 10) and KO mice (1.25 ± 0.16 nM, n = 13).
No significant change in DA concentration between saline-treated WT and A2AR KO mice was observed. and there was no significant effect of saline treatment on extracellular DA levels. Administration of cocaine (20 mg kg -1 , s.c.) markedly and significantly increased accumbal DA in both genotypes in comparison to saline-treated groups (P < 0.01), with a maximum effect 60mins post-injection (Fig 1a) . Cocaine initially increased accumbal DA concentrations in WT and A2AR KO in a similar manner (0-60min post injection). Cocaineevoked extracellular DA was sustained in WT mice, however, there was a reduction in DA levels in the later fractions of cocaine-treated A2AR KO mice compared to wildtype mice and this achieved statistical significance (P < 0.05) at 100 and 120 min after challenge.
Artificial CSF with a high concentration of potassium ([K + ] 50mM) was infused through the probe 120mins after the administration of challenge. There was a marked and very highly significant increase in DA concentration ([DA]120mins, 140mins; P < 0.001) in the NAc of saline and cocaine-treated WT and KO mice ( Fig. 1b) . The cocaine-treated groups had a lower evoked DA concentration, and the levels seen in saline or cocaine-treated KO mice were lower than those seen in WT mice, but these differences did not reach significance for the factors of treatment or genotype.
Altered ambulatory effects by cocaine A2AR KO mice
On the day of the experiment mice were exposed to the locomotor chambers for one hour, before the implantation of the microdialysis probe, in order to be habituated to the test environment. The mice were then left for a further two hours to recover from implantation and to habituate to the freely-moving counter-balance arm before their basal ambulatory activity was measured. The mice resumed normal exploratory and sleeping behaviours (data not shown).
Basal locomotor activity was similar in both genotypes. Acute cocaine administration induced a marked increase in locomotor behaviour in both genotypes compared to saline treated groups (Fig 2a) . The cocaine-induced locomotor effect was at a maximum 40-60 min post injection in both WT and KO mice. ANOVA analysis showed a highly significant difference in locomotor activity between treatment groups (saline versus cocaine treatment) and significant differences over time, with a significant challenge-time interaction. Further post hoc (Duncan's) analysis also indicated significant differences between genotype in cocaine-treated WT and A2AR KO mice; cocaine-induced locomotor activity was significantly higher in A2AR KO mice compared to WT mice (G (40-120mins), P < 0.05).
The number of small local movements was similar in both naïve WT and A2AR KO mice. Cocaine administration induced an increase in small local movements in both genotypes, the effect of which was at a maximum 100min post-injection (Fig 2b) .
Comparison of treatment groups showed that there was a highly significant increase in small local movements in cocaine-treated WT and A2AR KO mice compared to the saline treated controls. Analysis also indicated a very significant challenge-time interaction. Moreover, further post hoc (Duncan's) analysis showed that there was a significant difference between Wells et al. 11 small local movements in cocaine-treated wildtype and A2AR KO mice, with the significant attenuation of cocaine-induced small local movements in A2AR KO mice (G(40-100mins), P < 0.05).
Rest time in naïve wildtype and A2AR-/-mice was similar (Fig 2c) . Cocaine administration significantly decreased rest time in both genotypes in comparison to saline treated animals. The treatment-induced decrease was at a maximum 80min post-injection, where there was a significant difference in rest-time between cocaine treated wildtype and A2AR-/-mice. Knockout mice had a significantly greater cocaine-induced decrease in rest time compared to treated wildtype mice (P < 0.05).
Discussion
The aim of this study was to investigate the neurochemical response of accumbal DA in WT and A2AR KO mice to an acute administration of cocaine. The locomotor response of WT and A2AR KO mice was monitored throughout the treatment period. The findings of the present study indicate the presence of an altered neurochemical response to an acute cocaine challenge in mice lacking the A2AR receptor.
In agreement with recent in vivo microdialysis studies, no significant difference was observed in the basal accumbal DA between naïve wildtype and A2AR KO mice (Castane et al. , 2008 . In the present study, an acute challenge of cocaine increased extracellular DA in the accumbens of WT and A2AR KO mice in a similar manner. However, the evoked response was not sustained in the A2AR KO mice in comparison to WT mice. Previous studies ) have reported a significantly lower intake of cocaine in A2AR KO mice compared to WT littermates as measured by operant behaviour maintained by i.v. cocaine infusions and these authors suggested that the efficacy of the reinforcing effects and not the acute rewarding properties of cocaine were altered in these mice. Our results showing that the initial level of cocaine-evoked DA is the same but the DA release is not sustained in KO mice support the suggestion that it is the reinforcing effects and not the initial rewarding properties of cocaine that are reduced in mice lacking the A2A receptor.
The altered DAergic transmission in A2AR KO mice during the later stages of cocaine challenge may support a mechanism by which the lack of A2AR leads to changes in downstream cellular signalling. A2A and D2/3 receptors converge to modulate the effects of intracellular downstream signalling-pathways, by the regulation of dopamine-and cAMPregulated phosphoprotein of 32 kDa (DARPP-32) (Svenningsson et al. 1998; Svenningsson et al. 2000; Torvinen et al. 2005) . Regulation of DARPP-32 has been shown to play an Wells et al. 13 important role in the effects of drugs of abuse (Nairn et al. 2004; Svenningsson et al. 2005; Zachariou et al. 2006; Borgkvist and Fisone 2007) . Interestingly, DARPP-32 regulation is altered in A2AR KO mice (Svenningsson et al. 2000) ;and alterations in intracellular cascades downstream of dopamine release may affect the negative feedback mechanisms regulated by The intensity of basal ambulatory activity in naive A2AR KO mice was similar to WT mice in all variables measured (locomotion, small local movement and rest) (data not shown). This is in contrast with previous reports, where A2AR KO mice were shown to have a hypolocomotor phenotype (Ledent et al. 1997; Soria et al. 2006) . However, this is most likely to be due to differences in experimental paradigm, as in the aforementioned studies the ambulatory activity was measured directly after the initial introduction of the mice to a novel environment or recorded for a short experimental period (10min) after three days of short habituation, respectively. In the current study, the mice had an extended period of habituation pre-(1 hr) and post-(2 hr) probe implantation, during which mice of both genotypes displayed normal exploratory and sleep behaviours. In support of this, hypolocomotion was not observed in a study of A2AR KO mice subjected to an extended habituation period (120min) (Chen et al. 2000) . Therefore, the hypolocomotor phenotype observed in A2AR KO mice in the studies by Ledent et al (1997) and Soria et al (2006) is probably due to an initial increased level of anxiousness to novel environments, which decreases over extended periods 14 until the behaviour is similar to that of WT littermates. Indeed studies have shown that A2AR KO mice have been reported to exhibit increased levels of anxiety (Ledent et al. 1997) .
In this study cocaine-induced hyperlocomotion was significantly exacerbated in A2AR KO mice; this was accompanied by a decreased in cocaine-evoked small local movements and rest time compared to WT littermates. The increase in hyperlocomotion is in agreement with studies using pharmacological challenges (Poleszak and Malec 2002; Nagel et al. 2003; Filip et al. 2006 ), but in contrast to A2AR KO mice generated on in-bred hybrid backgrounds (Chen et al. 2000) . This discrepancy could be explained by a variation in background strain upon which the conditional knockouts were produced. The study in question used A2AR KO mice generated on an mixed inbred C57Bl/6 background (Chen et al. 1999) , where as the mice used in this study were generated on an outbred CD1 background (Ledent et al. 1997) . Genetic strain variations have been shown to influence modifications in behavioural strategy and drug-induced neurochemistry (He and Shippenberg 2000; Voikar et al. 2001) . Indeed, recent studies in hybrid 129-Steel/C57BL/6 mice with selective mutations of the A2AR in striatal region versus the forebrain show opposite locomotion phenotypes when challenged with cocaine (Shen et al. 2008 ). This suggests that the variation in the genetic background of these mice may be an important factor in explaining the discrepancies seen in acute cocaine- closed shapes indicate data from knockout animals, ■A2AR KO saline treated n=5, •A2AR KO cocaine treated n=5. Data are expressed as mean ± SEM. Post-hoc (Duncan's) analysis indicates significant differences within the factor of time between WT cocaine treated and A2AR KO cocaine treated mice *P < 0.05, **P < 0.01, ***P <0.001.
B)
Small local moves in WT and A2AR KO mice treated with either saline (5ml/kg s.c.) or cocaine (20mg/kg s.c.). Open shapes indicate data from wildtype animals, □WT saline treated n=6, ○WT cocaine treated n=7; closed shapes indicate data from knockout animals, ■ A2AR KO saline treated n=5, •A2AR KO cocaine treated n=5. Data are expressed as mean ± SEM. Post-hoc (Duncan's) analysis indicates significant differences within the factor of time between WT cocaine treated and A2AR KO cocaine treated mice *P < 0.05, **P < 0.01, ***P < 0.001. cocaine treated and A2AR KO cocaine treated mice *P < 0.05, **P < 0.01, ***P <0.001. Mice were treated with either saline (5ml/kg s.c.) or cocaine (20mg/kg s.c.).
